https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=ETH-LAD
ETH-LAD - 版本历史
2026-07-18T07:34:49Z
在这个wiki上该页的修订历史
MediaWiki 1.43.9
https://arolstar52-zhtest.hf.space/index.php?title=ETH-LAD&diff=4522076&oldid=prev
imported>Jimmy-bot：机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药
2025-08-15T10:32:28Z
<p>机器人: 尚未清空的已重定向分类） （<a href="/index.php?title=Cat:%E7%8B%A1%E8%A9%90%E5%AE%B6%E8%97%A5%E7%89%A9&action=edit&redlink=1" class="new" title="Cat:狡詐家藥物（页面不存在）">Cat:狡詐家藥物</a>→<a href="/index.php?title=Cat:%E7%AD%96%E5%88%92%E8%8D%AF&action=edit&redlink=1" class="new" title="Cat:策划药（页面不存在）">Cat:策划药</a></p>
<p><b>新页面</b></p><div>{{Infobox drug<br />
| Verifiedfields = changed<br />
| Watchedfields = changed<br />
| verifiedrevid = 414446334<br />
| IUPAC_name = (6a''R'',9''R'')-''N'',''N''-diethyl-7-ethyl-4,6,6a,7,8,9-<br>hexahydroindolo-[4,3-''fg'']quinoline-9-carboxamide<br />
| image = ETH-LAD_structure.png<br />
| width = 200<br />
<br />
<!--Clinical data--><br />
| tradename =<br />
| legal_AU =<br />
| legal_CA =<br />
| legal_DE = NpSG<br />
| legal_UK = Class A<br />
| legal_US = <br />
| legal_status = Illegal in France<ref>{{cite web|date=20 May 2021|title=Arrêté du 20 mai 2021 modifiant l'arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants|url=https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000043523554|website=www.legifrance.gouv.fr|language=fr|access-date=2024-10-05|archive-date=2023-02-07|archive-url=https://web.archive.org/web/20230207101535/https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000043523554|dead-url=no}}</ref><br />
| routes_of_administration = [[wikt:oral|Oral]]<br />
<br />
<!--Pharmacokinetic data--><br />
| metabolism = Hepatic<br />
| excretion = Renal<br />
<br />
<!--Identifiers--><br />
| CAS_number_Ref = {{cascite|correct|??}}<br />
| CAS_number = 65527-62-0<br />
| PubChem = 44457783<br />
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}<br />
| ChemSpiderID = 21106300<br />
| ChEMBL_Ref = {{ebicite|correct|EBI}}<br />
| ChEMBL = 22694<br />
| UNII_Ref = {{fdacite|changed|FDA}}<br />
| UNII = 21Z2736X9Q<br />
<br />
<!--Chemical data--><br />
| C=21 | H=27 | N=3 | O=1<br />
| smiles = CCN(C([C@@H]1C=C2C3=CC=CC4=C3C(C[C@H]2N(CC)C1)=CN4)=O)CC<br />
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}<br />
| StdInChI = 1S/C21H27N3O/c1-4-23(5-2)21(25)15-10-17-16-8-7-9-18-20(16)14(12-22-18)11-19(17)24(6-3)13-15/h7-10,12,15,19,22H,4-6,11,13H2,1-3H3/t15-,19-/m1/s1<br />
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}<br />
| StdInChIKey = MYNOUXJLOHVSMQ-DNVCBOLYSA-N<br />
| synonyms = ETH-LAD, 6-ethyl-6-nor-Lysergic acid diethylamide<br />
}}<br />
'''{{PAGENAME}}'''（6-ethyl-6-''nor''-lysergic acid diethylamide，6-乙基-6-去甲-麦角酸二乙酰胺）是一种[[有机化合物]]，化学式为[[C21H27N3O|C<sub>21</sub>H<sub>27</sub>N<sub>3</sub>O]]，为[[迷幻药物]][[麥角酸二乙酰胺]]（LSD）的[[同系物]]，最早由[[亚历山大·舒尔金]]在其著作《{{link-en|TiHKAL：延续|TiHKAL}}》（''TIHKAL: The Continuation''）中提出<ref name="pmid4032428">{{Cite journal |last=Hoffman |first=Andrew J. |last2=Nichols |first2=David E. |title=Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives |url=https://pubs.acs.org/doi/abs/10.1021/jm00147a022 |journal=Journal of Medicinal Chemistry |date=1985-09-01 |volume=28 |issue=9 |page=1252-1255 |doi=10.1021/jm00147a022 |issn=0022-2623 |pmid=4032428 |access-date=2025-04-13}}</ref>。<br />
<br />
==参考文献==<br />
{{reflist}}<br />
<br />
==外部链接==<br />
* [https://www.erowid.org/library/books_online/tihkal/tihkal12.shtml ETH-LAD entry in TIHKAL] {{Wayback|url=https://www.erowid.org/library/books_online/tihkal/tihkal12.shtml |date=20241206121112 }}<br />
* [http://isomerdesign.com/PiHKAL/read.php?domain=tk&id=12 ETH-LAD entry in Isomerdesign] {{Wayback|url=http://isomerdesign.com/PiHKAL/read.php?domain=tk&id=12 |date=20240506001430 }}<br />
<br />
[[Category:策划药]]<br />
[[Category:麦角酰胺]]<br />
[[Category:迷幻药物]]<br />
[[Category:宗教致幻剂]]</div>
imported>Jimmy-bot